GLP-1 receptor agonist therapy for type 2 diabetes or obesity is associated with a significantly lower risk of developing colon cancer.

Younger colorectal cancer patients have abnormally stiff colon tissue that promotes tumor growth, pointing to biomechanical forces as a key factor in early-onset disease.

Please provide your email address to receive an email when new articles are posted on . Patients with stage III or high-risk stage II colon cancer in a structured exercise program had 28% lower risk ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

After my brother was diagnosed with colorectal cancer, I read that it's often treated with surgery first. Can you tell me more about the surgery?

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

Colon cancers are especially tough to treat in their advanced stages A new trial finds the use of two immunotherapy drugs plus standard chemo nearly doubled survival times in patients with these ...

Serial circulating tumor DNA analysis can demonstrate rapid clonal dynamics that evolve during response and resistance to both standard chemotherapy and targeted therapy of BRAF-mutant colon cancer ...

Colorectal cancer often spreads to the liver, requiring prolonged chemotherapy. But now, doctors are turning to hepatic artery infusion. This therapy delivers chemo directly into the liver, and that, ...

WASHINGTON (Reuters) - Hormone replacement therapy may raise a woman's risk of breast cancer and heart disease but it lowers her risk of colon cancer, according to two studies released on Wednesday.